Literature DB >> 26843007

APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults.

Warren D Taylor1,2, Brian Boyd3, Rachel Turner3, Douglas R McQuoid4, Allison Ashley-Koch5, James R MacFall6, Ayman Saleh7, Guy G Potter4.   

Abstract

The APOE ε4 allele is associated with cognitive deficits and brain atrophy in older adults, but studies in younger adults are mixed. We examined APOE genotype effects on cognition and brain structure in younger adults and whether genotype effects differed by age and with presence of depression. 157 adults (32 % ε4 carriers, 46 % depressed) between 20 and 50 years of age completed neuropsychological testing, 131 of which also completed 3 T cranial MRI. We did not observe a direct effect of APOE genotype on cognitive performance or structural MRI measures. A significant genotype by age interaction was observed for executive function, where age had less of an effect on executive function in ε4 carriers. Similar interactions were observed for the entorhinal cortex, rostral and caudal anterior cingulate cortex and parahippocampal gyrus, where the effect of age on regional volumes was reduced in ε4 carriers. There were no significant interactions between APOE genotype and depression diagnosis. The ε4 allele benefits younger adults by allowing them to maintain executive function performance and volumes of cingulate and temporal cortex regions with aging, at least through age fifty years.

Entities:  

Keywords:  Aging; Apoe; Cognition; Depression; MRI

Mesh:

Substances:

Year:  2017        PMID: 26843007      PMCID: PMC4972704          DOI: 10.1007/s11682-016-9522-9

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  63 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

Review 2.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

3.  Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Authors:  Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Arch Gen Psychiatry       Date:  2010-03

4.  APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures.

Authors:  J M Rusted; S L Evans; S L King; N Dowell; N Tabet; P S Tofts
Journal:  Neuroimage       Date:  2012-10-11       Impact factor: 6.556

5.  Differential effects of the APOE genotype on brain function across the lifespan.

Authors:  N Filippini; K P Ebmeier; B J MacIntosh; A J Trachtenberg; G B Frisoni; G K Wilcock; C F Beckmann; S M Smith; P M Matthews; C E Mackay
Journal:  Neuroimage       Date:  2010-08-10       Impact factor: 6.556

6.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Authors:  Johanna Lind; Anne Larsson; Jonas Persson; Martin Ingvar; Lars-Göran Nilsson; Lars Bäckman; Rolf Adolfsson; Marc Cruts; Kristel Sleegers; Christine Van Broeckhoven; Lars Nyberg
Journal:  Neurosci Lett       Date:  2006-01-06       Impact factor: 3.046

Review 7.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

8.  Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

Authors:  R J Caselli; E M Reiman; D Osborne; J G Hentz; L C Baxter; J L Hernandez; G G Alexander
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  APOE related hippocampal shape alteration in geriatric depression.

Authors:  Anqi Qiu; Warren D Taylor; Zheen Zhao; James R MacFall; Michael I Miller; Cynthia R Key; Martha E Payne; David C Steffens; K Ranga R Krishnan
Journal:  Neuroimage       Date:  2008-10-28       Impact factor: 6.556

View more
  8 in total

1.  A bayesian approach to examining default mode network functional connectivity and cognitive performance in major depressive disorder.

Authors:  Rui Wang; Kimberly M Albert; Warren D Taylor; Brian D Boyd; Justin Blaber; Ilwoo Lyu; Bennett A Landman; Jennifer Vega; Sepideh Shokouhi; Hakmook Kang
Journal:  Psychiatry Res Neuroimaging       Date:  2020-05-17       Impact factor: 2.376

2.  Double-wavelet transform for multi-subject resting state functional magnetic resonance imaging data.

Authors:  Minchun Zhou; Brian D Boyd; Warren D Taylor; Hakmook Kang
Journal:  Stat Med       Date:  2021-10-01       Impact factor: 2.373

3.  Cognitive performance in antidepressant-free recurrent major depressive disorder.

Authors:  Kimberly M Albert; Guy G Potter; Douglas R McQuoid; Warren D Taylor
Journal:  Depress Anxiety       Date:  2018-04-10       Impact factor: 6.505

4.  Brain network functional connectivity and cognitive performance in major depressive disorder.

Authors:  Kimberly M Albert; Guy G Potter; Brian D Boyd; Hakmook Kang; Warren D Taylor
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

5.  Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression.

Authors:  Warren D Taylor; Brian D Boyd; Damian Elson; Patricia Andrews; Kimberly Albert; Jennifer Vega; Paul A Newhouse; Neil D Woodward; Hakmook Kang; Sepideh Shokouhi
Journal:  Am J Geriatr Psychiatry       Date:  2020-09-28       Impact factor: 4.105

6.  APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.

Authors:  Sheida Rabipour; Sricharana Rajagopal; Elsa Yu; Stamatoula Pasvanis; Marie-Elyse Lafaille-Magnan; John Breitner; M Natasha Rajah
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  Apolipoprotein E Homozygous ε4 Allele Status: A Deteriorating Effect on Visuospatial Working Memory and Global Brain Structure.

Authors:  Janik Goltermann; Ronny Redlich; Katharina Dohm; Dario Zaremba; Jonathan Repple; Claas Kaehler; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Verena Enneking; Emily Schlaghecken; Lara Fleischer; Tim Hahn; Harald Kugel; Andreas Jansen; Axel Krug; Katharina Brosch; Igor Nenadic; Simon Schmitt; Frederike Stein; Tina Meller; Dilara Yüksel; Elena Fischer; Marcella Rietschel; Stephanie H Witt; Andreas J Forstner; Markus M Nöthen; Tilo Kircher; Anbupalam Thalamuthu; Bernhard T Baune; Udo Dannlowski; Nils Opel
Journal:  Front Neurol       Date:  2019-05-27       Impact factor: 4.003

8.  Accelerated brain aging predicts impaired cognitive performance and greater disability in geriatric but not midlife adult depression.

Authors:  Seth Christman; Camilo Bermudez; Lingyan Hao; Bennett A Landman; Brian Boyd; Kimberly Albert; Neil Woodward; Sepideh Shokouhi; Jennifer Vega; Patricia Andrews; Warren D Taylor
Journal:  Transl Psychiatry       Date:  2020-09-18       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.